Pfizer Inc Stock Performance
| PFE Stock | USD 24.47 0.11 0.45% |
On a scale of 0 to 100, Pfizer holds a performance score of 10. The company holds a Beta of 0.9, which implies possible diversification benefits within a given portfolio. Pfizer returns are very sensitive to returns on the market. As the market goes up or down, Pfizer is expected to follow. Please check Pfizer's total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Pfizer's historical price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Pfizer exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.45) | Five Day Return (4.34) | Year To Date Return (8.04) | Ten Year Return (26.76) | All Time Return 5.6 K |
Forward Dividend Yield 0.071 | Payout Ratio | Last Split Factor 1054:1000 | Forward Dividend Rate 1.72 | Dividend Date 2025-09-02 |
| Pfizer dividend paid on 13th of June 2025 | 06/13/2025 |
1 | Pfizer Announces Positive Results For Hemophilia Treatment And Declares 0.43 Dividend | 06/26/2025 |
2 | Trump Administration official restricted COVID vaccine approvals, overruling FDA staff | 07/02/2025 |
3 | EU chief Ursula von der Leyen comfortably survives confidence vote after censure motion | 07/10/2025 |
4 | Will Pfizer Beat Estimates Again in Its Next Earnings Report | 07/11/2025 |
5 | Cutter CO Brokerage Inc. Sells 11,052 Shares of Pfizer Inc. | 07/14/2025 |
6 | Zohran Mamdani sticks to socialist guns, tax the rich plan during highly anticipated sitdown with NYC big business leaders | 07/15/2025 |
7 | Pfizer Sees Surge in Bullish Options Activity PFE Stock News | 07/16/2025 |
8 | Morgan Stanley Maintains a Hold on Pfizer | 07/18/2025 |
| Begin Period Cash Flow | 2.9 B | |
| Total Cashflows From Investing Activities | 2.7 B |
Pfizer Relative Risk vs. Return Landscape
If you would invest 2,163 in Pfizer Inc on April 20, 2025 and sell it today you would earn a total of 284.00 from holding Pfizer Inc or generate 13.13% return on investment over 90 days. Pfizer Inc is generating 0.2113% of daily returns assuming volatility of 1.5665% on return distribution over 90 days investment horizon. In other words, 14% of stocks are less volatile than Pfizer, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Pfizer Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pfizer's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pfizer Inc, and traders can use it to determine the average amount a Pfizer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1349
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PFE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.57 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Pfizer is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding it to a well-diversified portfolio.
Pfizer Fundamentals Growth
Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.
| Return On Equity | 0.0862 | ||||
| Return On Asset | 0.0479 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 183.72 B | ||||
| Shares Outstanding | 5.69 B | ||||
| Price To Earning | 9.48 X | ||||
| Price To Book | 1.55 X | ||||
| Price To Sales | 2.24 X | ||||
| Revenue | 63.63 B | ||||
| Gross Profit | 46.49 B | ||||
| EBITDA | 18.13 B | ||||
| Net Income | 8.05 B | ||||
| Cash And Equivalents | 2.85 B | ||||
| Cash Per Share | 6.44 X | ||||
| Total Debt | 63.65 B | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 1.59 X | ||||
| Book Value Per Share | 15.89 X | ||||
| Cash Flow From Operations | 12.74 B | ||||
| Earnings Per Share | 1.38 X | ||||
| Market Capitalization | 139.75 B | ||||
| Total Asset | 213.4 B | ||||
| Retained Earnings | 116.72 B | ||||
| Working Capital | 7.36 B | ||||
| Current Asset | 43.8 B | ||||
| Current Liabilities | 29.4 B | ||||
About Pfizer Performance
By analyzing Pfizer's fundamental ratios, stakeholders can gain valuable insights into Pfizer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pfizer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pfizer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 241.21 | 270.47 | |
| Return On Tangible Assets | 0.09 | 0.11 | |
| Return On Capital Employed | 0.09 | 0.08 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.09 | 0.09 |
Things to note about Pfizer Inc performance evaluation
Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 68.0% of the company shares are owned by institutional investors | |
| On 13th of June 2025 Pfizer paid $ 0.43 per share dividend to its current shareholders | |
| Latest headline from insidermonkey.com: Morgan Stanley Maintains a Hold on Pfizer |
- Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
- Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Transaction History View history of all your transactions and understand their impact on performance |